NLRP3 and rheumatoid arthritis: Notably, patients with RA are at an increased risk of premature death due to accelerated atherosclerosis in cardiovascular comorbidities, while NLRP3 inflammasome activation and production of IL-1β, TNF-α, and IL-6 are also key immune mediators of RA [9, 21 –24].